Generic Pills and Generic Medication

A generic drug (generic drugs, short: generics) is a drug defined as "a drug product that is comparable to a brand/reference listed drug product in dosage form, strength, quality and performance characteristics, and intended use.” It has also been defined as a term referring to any drug marketed under its chemical name without advertising or to the chemical makeup of a drug rather than to the advertised brand name under which the drug is sold. Although they may not be associated with a particular company, generic drugs are subject to the regulations of the governments of countries where they are dispensed. Global generic are labelled with the name of the manufacturer and the adopted name (non-proprietary name) of the drug. A generic drug must contain the same active ingredients as the original formulation.

The "Generic Drugs Market: 2015 - 2030 - Opportunities, Challenges, Strategies & Forecasts" report presents an in-depth assessment of the generic drugs ecosystem including technology, economics, key trends, market drivers, challenges, investment potential, regulatory landscape, leading therapies, opportunities, future road map, value chain, ecosystem player profiles and strategies. The report also presents market size forecasts for generic drugs from 2015 through to 2030. The forecasts are segmented for over 10 therapeutic areas, 3 brand classifications, 5 regions and 25 leading countries

U.S. Food and Drug Administration’s Centre for Drug Evaluation and Research (CDER) announced the approval of plans to elevate the Office of Generic Drugs (OGD) to an office that reports directly to the centre director.  This reorganization will strengthen OGD’s operations and enable the office to meet the evolving needs of generic drug review. Generic prescription drugs make up 84% of prescriptions filled in the United States and provide affordable access to treatments for many patients and consumers. The American public depends on FDA to ensure that generic drugs perform clinically in the same way as their brand name counterparts.  The OGD reorganization is a critical and necessary step in recognizing the importance of generic drugs to public health and our national economy

    Related Conference of Generic Pills and Generic Medication

    July 03-04, 2017

    4th Annual Congress on Drug Discovery & Designing

    Bangkok, Thailand
    August 10-12, 2017

    8th Asian Biologics and Biosimilars Congress

    Beijing, China
    September 20-21, 2017

    10th Pharmacovigilance Congress

    Charlotte, North Carolina, USA
    September 25-26, 2017(10 Plenary Forums- 1 Event)

    7th International Conference and Exhibition on Pharmaceutical Regulatory Affairs and IPR

    Chicago, Illinois, USA
    September 25-26, 2017
    (10 Plenary Forums - 1Event)

    6th International Conference and Exhibition on GMP, GCP & Quality Control

    Chicago, Illinois, USA
    October 02-04, 2017

    World Congress on Antibiotics: R&D, Market

    Atlanta, USA
    October 16-18, 2017

    12th World Pharma Congress

    Budapest, Hungary
    October 16-18, 2017

    11th World Drug Delivery Summit

    (10 Plenary Forums - 1Event)
    Baltimore, Maryland, USA
    October 16-17, 2017

    10th International Conference and Exhibition on Biologics and Biosimilars

    San Francisco, California, USA
    November 09-11, 2017

    4th European Biopharma Congress

    Vienna, Austria

    Generic Pills and Generic Medication Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in